Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.210
+0.140 (6.76%)
Aug 13, 2025, 4:00 PM - Market closed
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$115,090
Profits / Employee
-$282,970
Market Cap
194.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IPHA News
- 15 days ago - Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference - Business Wire
- 2 months ago - Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences - Business Wire
- 2 months ago - Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress - Business Wire
- 2 months ago - Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences - Business Wire
- 2 months ago - Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides - Business Wire
- 2 months ago - Outcome of Innate Pharma's 2025 Annual General Meeting - Business Wire
- 3 months ago - Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting - Business Wire
- 3 months ago - Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress - Business Wire